Smoking Cessation for HIV/AIDS Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

706 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Automated Video-Assisted Smoking Treatment for People Living With HIV

NCT05014282

Smoking Cessation

ACTIVE_NOT_RECRUITING NA

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

NCT02302859

Tobacco Use Cessation

TERMINATED NA

A Mobile Intervention to Promote Cessation in HIV-infected Smokers

NCT02432482

Tobacco Use HIV-1-infection

COMPLETED NA

Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

NCT03904186

Human Immunodeficiency Virus Smoking Cessation Smoking, Cigarette +4 more

ACTIVE_NOT_RECRUITING NA

Patch Study - Intervention for HIV Positive Smokers

NCT02982772

Smoking Cessation HIV

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

If you agree to take part in this study, researchers will first do a test to learn what the CO level of your blood is. To do this test, you will be asked to blow into a cardboard tube. If the test finds that you are ineligible, you will not be able to continue on this study.

If you are found to be eligible, you will be enrolled in this study and asked to complete an interview that should last about 1 hour. During this interview, you will be asked basic questions, such as your age, education level, and smoking history. You will also be asked questions about your mood, quality of life, and stress. You will then be asked to complete a short test that involves completing some basic tasks, such as remembering several words and drawing a simple shape. This test, which will take about 2-5 minutes to complete, is used to measure attention and concentration.

You will then be randomly assigned (as in the toss of a coin) to one of two treatment groups. There is an equal chance of being assigned to either group.

If you are assigned to Group 1, you will receive advice from your physician/provider to stop smoking and written materials designed to help you quit smoking.

If you are assigned to Group 2, you will receive the advice from your physician/provider to quit smoking and the written materials, but you also be given a cell phone and be called 11 times over the course of an 12 to 13 week period. During these calls, which will last about 10 minutes, you will be asked to talk about smoking and quitting smoking. Access to a hotline number that you can call to speak with a counselor about quitting smoking will also be given to you if you are assigned to group 2. Participants in Group 1 will not get the number to the hotline. There is a limited number of prepaid minutes on the phone, so participants who receive a cell phone should make an effort to save enough minutes to complete this study.

You will be asked to complete three more interviews about 3-, 6-, and 12-months after the first interview. During these interviews, you will again be asked questions about your smoking behavior, mood, quality of life, and stress. All three of these interviews will take about one hour to complete. Your participation in this study will be complete after the 12-month interview.

Lost, stolen, or broken cell phones will not be replaced, but participants will remain on study.

This is an investigational study. Up to 705 participants will take part in this research study. All participants will be enrolled at Thomas Street Clinic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Immunodeficiency Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recommended Standard of Care

Recommended Standard of Care (RSOC) = Physician Advice + Written Materials

Group Type OTHER

Recommended Standard of Care

Intervention Type OTHER

Advice from your physician to stop smoking and written materials designed to help you quit smoking.

RSOC + Cell Phone Intervention

Recommended Standard of Care (RSOC) + Cell Phone Intervention

Group Type OTHER

Cell Phone Intervention

Intervention Type BEHAVIORAL

Study participants called on a cell phone 11 times over course of a 12 - 13 week period, during 10 minute calls questions asked about smoking and quitting smoking.

Recommended Standard of Care

Intervention Type OTHER

Advice from your physician to stop smoking and written materials designed to help you quit smoking.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cell Phone Intervention

Study participants called on a cell phone 11 times over course of a 12 - 13 week period, during 10 minute calls questions asked about smoking and quitting smoking.

Intervention Type BEHAVIORAL

Recommended Standard of Care

Advice from your physician to stop smoking and written materials designed to help you quit smoking.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CPI RSOC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. HIV-positive
2. 18 years of age or older
3. Current, regular smoker (\> 5 cigarettes per day for the past 30 days, breath CO of \> 7ppm)
4. English or Spanish speaking
5. Able to provide written informed consent to participate
6. Willing to set a quit date within 1 week of baseline assessment

Exclusion Criteria

1. Physician deemed ineligibility based on medical (HIV related or other condition) or psychiatric condition
2. Current participation in another smoking cessation program

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No